Universal Medical raises $75M in five-year China bond sale
What's the deal? Genertec Universal Medical GroupDealroom has a profile for this one. Try Dealroom → has completed a US$68.8M corporate bond issuance in mainland China, its third tranche, priced at par with a fixed 1.74% interest rate. The Hong Kong-listed healthcare group raised the debt through its wholly owned subsidiary, China Universal LeasingDealroom has a profile for this one. Try Dealroom →.
The terms: The bonds run for a basic five-year term from September 23, 2026. They include an issuer repurchase option and coupon adjustment rights at the end of the third and fourth years, with a matching sell-back option for investors.
What's the endgame? Universal MedicalDealroom has a profile for this one. Try Dealroom → operates in healthcare-related leasing and financing across China, supporting the sector's capital and equipment needs. The company said the raise adds funding flexibility in the domestic bond market and may support its leasing and healthcare financing operations.
Why now? The low 1.74% coupon reflects the cost of borrowing available to the group in China's onshore bond market. The structured options give both the issuer and investors room to adjust as rates move over the five-year term.
The signal: The round is modest by market standards, landing in the bottom range of comparable deals. For Universal Medical, which carries a market capitalisation of US$1.1B, the issuance is a routine capital-base move rather than a headline raise — a steady tap of onshore debt to fund its medical finance business.
Read more: tipranks.com
Image credit: daveynin
